Gilead Sciences (GILD) 94.26 $GILD
Final Glance: Biotechnology companies
AP - Wed Dec 31, 6:58PM CST
NEW YORK (AP) — Shares of some top biotechnology companies were down at the close of trading:
GILD: 94.26 (-1.02), AMGN: 159.29 (-1.34), CELG: 111.86 (-1.68)
5 Biotech Stocks With Big News Due In January
at Investor's Business Daily - Wed Dec 31, 12:15PM CST
The biotech industry is set to hit the ground running in 2015, with January alone bringing a passel of potentially stock-moving events by some of the biggest players. The second full week of the month will bring the annual JPMorgan Healthcare...
BIIB: 339.45 (-2.74), ESRX: 84.67 (-1.08), VRTX: 118.80 (-0.35), GILD: 94.26 (-1.02), ABBV: 65.44 (-0.86), BMY: 59.03 (-0.36), CELG: 111.86 (-1.68)
These 3 Biotechs Are Looking at a Happy New Year
Todd Campbell, The Motley Fool - Motley Fool - Wed Dec 31, 11:33AM CST
This healthcare edition of Industry Focus takes a look at three biotech stocks and why each company is positioned for a great performance in the coming year. If your portfolio could use some exposure to healthcare and biotechs, join the Fool's...
NFLX: 341.61 (-1.62), MDVN: 99.61 (+0.72), JNJ: 104.57 (-0.79), AMZN: 310.35 (+0.05), JPM: 62.58 (-0.57), GILD: 94.26 (-1.02), AGIO: 112.04 (-0.13), AAPL: 110.38 (-2.14), XLRN: 38.96 (+1.30), CELG: 111.86 (-1.68)
Early Glance: Biotechnology companies
AP - Wed Dec 31, 9:52AM CST
NEW YORK (AP) — Shares of some top biotechnology companies are up at 10 a.m.:
GILD: 94.26 (-1.02), AMGN: 159.29 (-1.34), CELG: 111.86 (-1.68)
The Zacks Analyst Blog Highlights: Gilead Sciences, AbbVie, Vertex Pharmaceuticals and Achillion Pharmaceuticals
PR Newswire - Wed Dec 31, 8:30AM CST
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Gilead Sciences Inc. (Nasdaq:GILD-Free Report), AbbVie (NYSE:ABBV-Free Report), Vertex Pharmaceuticals Inc. (Nasdaq:VRTX-Free Report) and Achillion Pharmaceuticals (Nasdaq:ACHN-Free Report).
VRTX: 118.80 (-0.35), GILD: 94.26 (-1.02)
RBC provides commentary on Viekira Pak ramp up
Seeking Alpha - at Seeking Alpha - Wed Dec 31, 7:12AM CST
GILD: 94.26 (-1.02), ABBV: 65.44 (-0.86)
Most active Nasdaq-traded stocks
AP - Tue Dec 30, 5:31PM CST
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:
MU: 35.01 (-0.39), GILD: 94.26 (-1.02), FB: 78.02 (-1.20), ARCP: 9.05 (-0.06), MSFT: 46.45 (-0.57), INTC: 36.29 (-0.47), AAPL: 110.38 (-2.14), CSCO: 27.82 (-0.54)
Gilead/J&J Expand TAF-based HIV Drugs Related Agreement - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 30, 4:00PM CST
Gilead Sciences, Inc. announced that it has expanded its agreement with Janssen R&D Ireland, a subsidiary of Johnson & Johnson.
AGN: 212.59 (-0.81), JNJ: 104.57 (-0.79), ACT: 257.41 (-2.16), GILD: 94.26 (-1.02)
Will Biotech Fire On All Cylinders In 2015?
Life Sciences Report - at Seeking Alpha - Tue Dec 30, 3:15PM CST
Making predictions for the New Year may feel as productive as peering into a crystal ball. But in the life sciences, hard science and long experience back prognostication. The biotech market enjoyed a stellar 2013 and withstood a solid check in early...
MDT: 72.20 (-0.87), PFE: 31.15 (-0.23), CLDX: 18.25 (+0.07), COV: 102.28 (-0.94), INCY: 73.11 (+0.09), NBS: 3.77 (+0.02), BMY: 59.03 (-0.36), OMER: 24.78 (+0.90), CELG: 111.86 (-1.68), ISIS: 61.74 (+0.01), GILD: 94.26 (-1.02), NVAX: 5.93 (+0.11), AZN: 70.38 (-0.31), CEMP: 23.51 (+0.54), FPRX: 27.00 (+0.81)
Morgan Stanley Provides Some Sage Words On Gilead Sciences
Bret Jensen - at Seeking Alpha - Tue Dec 30, 2:05PM CST
GILD: 94.26 (-1.02)
Gilead Long-Term Prognosis Is Promising
Stock Traders Daily - at Seeking Alpha - Tue Dec 30, 1:10PM CST
ESRX: 84.67 (-1.08), GILD: 94.26 (-1.02), MRK: 56.79 (-0.86), ABBV: 65.44 (-0.86), BMY: 59.03 (-0.36)
Portfolio Changes For The Fourth Quarter Of 2014
Alexander J. Poulos - at Seeking Alpha - Tue Dec 30, 12:35PM CST
HSY: 103.93 (-1.72), C: 54.11 (-0.73), XOM: 92.45 (-0.57), GOOG: 526.40 (-4.02), CCE: 44.22 (-0.63), SLB: 85.41 (-1.03), ZROZ: 119.82 (+0.41), YHOO: 50.51 (-0.71), V: 262.20 (-2.35), IBM: 160.44 (+0.39), S: 4.15 (+0.03), DE: 88.47 (-0.99), GOOGL: 530.66 (-4.62), TMUS: 26.94 (-0.06), BK: 40.57 (-0.46), AAPL: 110.38 (-2.14), WAG: 76.05 (-0.49), REGN: 410.25 (+1.91), TMK: 54.17 (-0.87), HTZ: 24.94 (-0.24), EMN: 75.86 (-0.72), FB: 78.02 (-1.20), AMGN: 159.29 (-1.34), WFC: 54.82 (-0.60), TSM: 22.38 (-0.06), ALL: 70.25 (-0.69), ORCL: 44.97 (-0.37), TOT: 51.20 (-0.32), GILD: 94.26 (-1.02), MCD: 93.70 (-0.55), FLT: 148.71 (-0.25), VIAB: 75.25 (-1.14), VZ: 46.78 (-0.55), CTSH: 52.66 (-0.49), GIS: 53.33 (-1.02), CL: 69.19 (-0.85), CBS: 55.34 (-0.49), BABA: 103.94 (-1.81)
Midday Glance: Biotechnology companies
AP - Tue Dec 30, 12:22PM CST
NEW YORK (AP) — Shares of some top biotechnology companies are down at 1 p.m.:
GILD: 94.26 (-1.02), AMGN: 159.29 (-1.34), CELG: 111.86 (-1.68)
Gauging The Impact Of Express Scripts/AbbVie Agreement On Gilead
Kanak Kanti De - at Seeking Alpha - Tue Dec 30, 11:36AM CST
GILD: 94.26 (-1.02)
Arrowhead up on rumor of Gilead interest
Seeking Alpha - at Seeking Alpha - Tue Dec 30, 11:26AM CST
GILD: 94.26 (-1.02), ARWR: 7.38 (-0.19)
3 Biotech Stocks That Soared Past Gilead in 2014 - Analyst Blog
Arpita Dutt - Zacks Investment Research - Tue Dec 30, 9:41AM CST
Gilead (GILD) has been under pressure due to the pricing of its hepatitis C virus (HCV) treatments.
JNJ: 104.57 (-0.79), ESRX: 84.67 (-1.08), VRTX: 118.80 (-0.35), GILD: 94.26 (-1.02), ACHN: 12.25 (-0.04), ABBV: 65.44 (-0.86)
Factors Moving Markets: Complementary Reports on United Parcel Service, Gilead, Manitowoc, EMC Corporation, and LiveDeal
PR Newswire - Tue Dec 30, 8:10AM CST
Moments ago, Analysts Review released new research updates concerning several important developing situations including United Parcel Service, (NYSE: UPS), Gilead (NASDAQ: GILD), Manitowoc (NYSE: MTW), EMC Corporation (NYSE: EMC), and LiveDeal (NASDAQ: LIVE). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.
GILD: 94.26 (-1.02), EMC: 29.74 (-0.41), LIVE: 3.14 (-0.35), MTW: 22.10 (-0.24), UPS: 111.17 (-0.97)
Final Glance: Biotechnology companies
AP - Wed Dec 31, 6:58PM CST
NEW YORK (AP) — Shares of some top biotechnology companies were down at the close of trading:
GILD: 94.26 (-1.02), AMGN: 159.29 (-1.34), CELG: 111.86 (-1.68)
5 Biotech Stocks With Big News Due In January
at Investor's Business Daily - Wed Dec 31, 12:15PM CST
The biotech industry is set to hit the ground running in 2015, with January alone bringing a passel of potentially stock-moving events by some of the biggest players. The second full week of the month will bring the annual JPMorgan Healthcare...
BIIB: 339.45 (-2.74), ESRX: 84.67 (-1.08), VRTX: 118.80 (-0.35), GILD: 94.26 (-1.02), ABBV: 65.44 (-0.86), BMY: 59.03 (-0.36), CELG: 111.86 (-1.68)
These 3 Biotechs Are Looking at a Happy New Year
Todd Campbell, The Motley Fool - Motley Fool - Wed Dec 31, 11:33AM CST
This healthcare edition of Industry Focus takes a look at three biotech stocks and why each company is positioned for a great performance in the coming year. If your portfolio could use some exposure to healthcare and biotechs, join the Fool's...
NFLX: 341.61 (-1.62), MDVN: 99.61 (+0.72), JNJ: 104.57 (-0.79), AMZN: 310.35 (+0.05), JPM: 62.58 (-0.57), GILD: 94.26 (-1.02), AGIO: 112.04 (-0.13), AAPL: 110.38 (-2.14), XLRN: 38.96 (+1.30), CELG: 111.86 (-1.68)
Early Glance: Biotechnology companies
AP - Wed Dec 31, 9:52AM CST
NEW YORK (AP) — Shares of some top biotechnology companies are up at 10 a.m.:
GILD: 94.26 (-1.02), AMGN: 159.29 (-1.34), CELG: 111.86 (-1.68)
The Zacks Analyst Blog Highlights: Gilead Sciences, AbbVie, Vertex Pharmaceuticals and Achillion Pharmaceuticals
PR Newswire - Wed Dec 31, 8:30AM CST
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Gilead Sciences Inc. (Nasdaq:GILD-Free Report), AbbVie (NYSE:ABBV-Free Report), Vertex Pharmaceuticals Inc. (Nasdaq:VRTX-Free Report) and Achillion Pharmaceuticals (Nasdaq:ACHN-Free Report).
VRTX: 118.80 (-0.35), GILD: 94.26 (-1.02)
RBC provides commentary on Viekira Pak ramp up
Seeking Alpha - at Seeking Alpha - Wed Dec 31, 7:12AM CST
GILD: 94.26 (-1.02), ABBV: 65.44 (-0.86)
Most active Nasdaq-traded stocks
AP - Tue Dec 30, 5:31PM CST
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:
MU: 35.01 (-0.39), GILD: 94.26 (-1.02), FB: 78.02 (-1.20), ARCP: 9.05 (-0.06), MSFT: 46.45 (-0.57), INTC: 36.29 (-0.47), AAPL: 110.38 (-2.14), CSCO: 27.82 (-0.54)
Gilead/J&J Expand TAF-based HIV Drugs Related Agreement - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 30, 4:00PM CST
Gilead Sciences, Inc. announced that it has expanded its agreement with Janssen R&D Ireland, a subsidiary of Johnson & Johnson.
AGN: 212.59 (-0.81), JNJ: 104.57 (-0.79), ACT: 257.41 (-2.16), GILD: 94.26 (-1.02)
Will Biotech Fire On All Cylinders In 2015?
Life Sciences Report - at Seeking Alpha - Tue Dec 30, 3:15PM CST
Making predictions for the New Year may feel as productive as peering into a crystal ball. But in the life sciences, hard science and long experience back prognostication. The biotech market enjoyed a stellar 2013 and withstood a solid check in early...
MDT: 72.20 (-0.87), PFE: 31.15 (-0.23), CLDX: 18.25 (+0.07), COV: 102.28 (-0.94), INCY: 73.11 (+0.09), NBS: 3.77 (+0.02), BMY: 59.03 (-0.36), OMER: 24.78 (+0.90), CELG: 111.86 (-1.68), ISIS: 61.74 (+0.01), GILD: 94.26 (-1.02), NVAX: 5.93 (+0.11), AZN: 70.38 (-0.31), CEMP: 23.51 (+0.54), FPRX: 27.00 (+0.81)
Morgan Stanley Provides Some Sage Words On Gilead Sciences
Bret Jensen - at Seeking Alpha - Tue Dec 30, 2:05PM CST
GILD: 94.26 (-1.02)
Gilead Long-Term Prognosis Is Promising
Stock Traders Daily - at Seeking Alpha - Tue Dec 30, 1:10PM CST
ESRX: 84.67 (-1.08), GILD: 94.26 (-1.02), MRK: 56.79 (-0.86), ABBV: 65.44 (-0.86), BMY: 59.03 (-0.36)
Portfolio Changes For The Fourth Quarter Of 2014
Alexander J. Poulos - at Seeking Alpha - Tue Dec 30, 12:35PM CST
HSY: 103.93 (-1.72), C: 54.11 (-0.73), XOM: 92.45 (-0.57), GOOG: 526.40 (-4.02), CCE: 44.22 (-0.63), SLB: 85.41 (-1.03), ZROZ: 119.82 (+0.41), YHOO: 50.51 (-0.71), V: 262.20 (-2.35), IBM: 160.44 (+0.39), S: 4.15 (+0.03), DE: 88.47 (-0.99), GOOGL: 530.66 (-4.62), TMUS: 26.94 (-0.06), BK: 40.57 (-0.46), AAPL: 110.38 (-2.14), WAG: 76.05 (-0.49), REGN: 410.25 (+1.91), TMK: 54.17 (-0.87), HTZ: 24.94 (-0.24), EMN: 75.86 (-0.72), FB: 78.02 (-1.20), AMGN: 159.29 (-1.34), WFC: 54.82 (-0.60), TSM: 22.38 (-0.06), ALL: 70.25 (-0.69), ORCL: 44.97 (-0.37), TOT: 51.20 (-0.32), GILD: 94.26 (-1.02), MCD: 93.70 (-0.55), FLT: 148.71 (-0.25), VIAB: 75.25 (-1.14), VZ: 46.78 (-0.55), CTSH: 52.66 (-0.49), GIS: 53.33 (-1.02), CL: 69.19 (-0.85), CBS: 55.34 (-0.49), BABA: 103.94 (-1.81)
Midday Glance: Biotechnology companies
AP - Tue Dec 30, 12:22PM CST
NEW YORK (AP) — Shares of some top biotechnology companies are down at 1 p.m.:
GILD: 94.26 (-1.02), AMGN: 159.29 (-1.34), CELG: 111.86 (-1.68)
Gauging The Impact Of Express Scripts/AbbVie Agreement On Gilead
Kanak Kanti De - at Seeking Alpha - Tue Dec 30, 11:36AM CST
GILD: 94.26 (-1.02)
Arrowhead up on rumor of Gilead interest
Seeking Alpha - at Seeking Alpha - Tue Dec 30, 11:26AM CST
GILD: 94.26 (-1.02), ARWR: 7.38 (-0.19)
3 Biotech Stocks That Soared Past Gilead in 2014 - Analyst Blog
Arpita Dutt - Zacks Investment Research - Tue Dec 30, 9:41AM CST
Gilead (GILD) has been under pressure due to the pricing of its hepatitis C virus (HCV) treatments.
JNJ: 104.57 (-0.79), ESRX: 84.67 (-1.08), VRTX: 118.80 (-0.35), GILD: 94.26 (-1.02), ACHN: 12.25 (-0.04), ABBV: 65.44 (-0.86)
Factors Moving Markets: Complementary Reports on United Parcel Service, Gilead, Manitowoc, EMC Corporation, and LiveDeal
PR Newswire - Tue Dec 30, 8:10AM CST
Moments ago, Analysts Review released new research updates concerning several important developing situations including United Parcel Service, (NYSE: UPS), Gilead (NASDAQ: GILD), Manitowoc (NYSE: MTW), EMC Corporation (NYSE: EMC), and LiveDeal (NASDAQ: LIVE). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.
GILD: 94.26 (-1.02), EMC: 29.74 (-0.41), LIVE: 3.14 (-0.35), MTW: 22.10 (-0.24), UPS: 111.17 (-0.97)
